SEI Investments’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $123K | Sell |
10,570
-6,273
| -37% | -$89.5K | ﹤0.01% | 3151 |
|
|
2026
Q1 | $283K | Sell |
16,843
-5,800
| -26% | -$104K | ﹤0.01% | 2843 |
|
|
2025
Q4 | $363K | Hold |
22,643
| – | – | ﹤0.01% | 2646 |
|
|
2025
Q3 | $280K | Buy |
22,643
+2,550
| +13% | +$29.9K | ﹤0.01% | 2492 |
|
|
2025
Q2 | $231K | Sell |
20,093
-202
| -1% | -$2.4K | ﹤0.01% | 2505 |
|
|
2025
Q1 | $304K | Buy |
+20,295
| New | +$340K | ﹤0.01% | 2334 |
|
|
2024
Q3 | – | Sell |
-35,193
| Closed | -$714K | – | 2698 |
|
|
2024
Q2 | $714K | Sell |
35,193
-1,110
| -3% | -$19.6K | ﹤0.01% | 2034 |
|
|
2024
Q1 | $620K | Buy |
36,303
+17,371
| +92% | +$273K | ﹤0.01% | 2043 |
|
|
2023
Q4 | $334K | Buy |
18,932
+1,739
| +10% | +$35K | ﹤0.01% | 2268 |
|
|
2023
Q3 | $413K | Buy |
17,193
+3,185
| +23% | +$78.2K | ﹤0.01% | 2187 |
|
|
2023
Q2 | $326K | Sell |
14,008
-452,613
| -97% | -$10.2M | ﹤0.01% | 2305 |
|
|
2023
Q1 | $10.3M | Sell |
466,621
-12,246
| -3% | -$287K | 0.02% | 823 |
|
|
2022
Q4 | $9.71M | Buy |
478,867
+2,871
| +0.6% | +$55.6K | 0.02% | 742 |
|
|
2022
Q3 | $6.42M | Sell |
475,996
-6,581
| -1% | -$111K | 0.01% | 974 |
|
|
2022
Q2 | $9.56M | Sell |
482,577
-6,907
| -1% | -$183K | 0.02% | 795 |
|
|
2022
Q1 | $15.5M | Sell |
489,484
-9,735
| -2% | -$273K | 0.03% | 589 |
|
|
2021
Q4 | $11.1M | Sell |
499,219
-35,523
| -7% | -$926K | 0.02% | 744 |
|
|
2021
Q3 | $14.8M | Sell |
534,742
-3,516
| -0.7% | -$107K | 0.03% | 573 |
|
|
2021
Q2 | $21M | Buy |
538,258
+2,363
| +0.4% | +$84.7K | 0.05% | 401 |
|
|
2021
Q1 | $15.4M | Sell |
535,895
-31,846
| -6% | -$1.09M | 0.04% | 472 |
|
|
2020
Q4 | $15M | Sell |
567,741
-39,835
| -7% | -$813K | 0.04% | 458 |
|
|
2020
Q3 | $9.28M | Buy |
607,576
+83,344
| +16% | +$1.75M | 0.03% | 575 |
|
|
2020
Q2 | $10.7M | Sell |
524,232
-65,373
| -11% | -$1.17M | 0.03% | 511 |
|
|
2020
Q1 | $6.07M | Sell |
589,605
-55,316
| -9% | -$1.55M | 0.02% | 664 |
|
|
2019
Q4 | $24.2M | Sell |
644,921
-6,805
| -1% | -$306K | 0.07% | 265 |
|
|
2019
Q3 | $30.3M | Buy |
651,726
+206,627
| +46% | +$9.61M | 0.08% | 233 |
|
|
2019
Q2 | $23.2M | Sell |
445,099
-4,247
| -0.9% | -$249K | 0.08% | 271 |
|
|
2019
Q1 | $30.9M | Sell |
449,346
-132,787
| -23% | -$8.9M | 0.1% | 194 |
|
|
2018
Q4 | $53.9M | Buy |
582,133
+6,472
| +1% | +$559K | 0.19% | 94 |
|
|
2018
Q3 | $66.7M | Sell |
575,661
-46,481
| -7% | -$5.24M | 0.24% | 63 |
|
|
2018
Q2 | $78.5M | Sell |
622,142
-16,581
| -3% | -$2.02M | 0.27% | 61 |
|
|
2018
Q1 | $69.1M | Buy |
638,723
+182,848
| +40% | +$20.2M | 0.27% | 62 |
|
|
2017
Q4 | $49.9M | Buy |
455,875
+58,402
| +15% | +$5.83M | 0.17% | 118 |
|
|
2017
Q3 | $39.2M | Sell |
397,473
-268,344
| -40% | -$26M | 0.14% | 145 |
|
|
2017
Q2 | $67.4M | Buy |
665,817
+247,042
| +59% | +$26.6M | 0.27% | 68 |
|
|
2017
Q1 | $48.4M | Buy |
418,775
+25,980
| +7% | +$3.02M | 0.21% | 95 |
|
|
2016
Q4 | $47.2M | Sell |
392,795
-22,246
| -5% | -$2.46M | 0.23% | 87 |
|
|
2016
Q3 | $46.6M | Sell |
415,041
-4,653
| -1% | -$536K | 0.24% | 91 |
|
|
2016
Q2 | $52M | Sell |
419,694
-19,073
| -4% | -$2.3M | 0.31% | 65 |
|
|
2016
Q1 | $49.3M | Buy |
438,767
+45,007
| +11% | +$4.68M | 0.31% | 67 |
|
|
2015
Q4 | $42.8M | Buy |
393,760
+100,169
| +34% | +$11.5M | 0.26% | 84 |
|
|
2015
Q3 | $29.3M | Buy |
293,591
+926
| +0.3% | +$101K | 0.27% | 84 |
|
|
2015
Q2 | $33.4M | Sell |
292,665
-9,764
| -3% | -$1.18M | 0.3% | 82 |
|
|
2015
Q1 | $31.6M | Buy |
302,429
+8,181
| +3% | +$872K | 0.27% | 84 |
|
|
2014
Q4 | $35.4M | Buy |
+294,248
| New | +$38.7M | 0.31% | 75 |
|
Other funds holding CLB
AI
DGI
CAMG
SEI Investments's CLB Position: Q2 2026 in Review
SEI Investments reduced its Core Laboratories (CLB) stake by 37% in Q2 2026, selling an estimated $89.5K and leaving 10,570 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3151.
SEI Investments first reported a position in CLB in Q4 2014 and has held it in 45 quarters since. The position peaked at $78.5M in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- SEI Investments held 10,570 shares of Core Laboratories worth $123K as of Q2 2026.
- SEI Investments sold 6,273 Core Laboratories shares in Q2 2026, an estimated $89.5K.
- Core Laboratories made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3151 holding.
- SEI Investments first reported a position in Core Laboratories in Q4 2014 and has held it in 45 quarters since.
- SEI Investments's Core Laboratories position peaked at $78.5M in Q2 2018.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.